All Cancer articles – Page 73
-
News
Cancer money may be spread wider in future
Public health minister Yvette Cooper has said that NHS cancer research money may in future be spread wider than the big three cancer research centres.
-
News
Cancer drugs probe 'should take only months'
NHS cancer 'czar' Mike Richards has told MPs he expects 'around a dozen' licensed cancer drugs currently prescribed by some health authorities to be formally assessed 'in the next few months'.
-
News
Ovarian cancer drug will cost HAs millions
Health authorities will have to find millions of pounds to fund cancer drugs after the National Institute for Clinical Excellence backed the use of paclitaxel to treat patients with ovarian cancer.
-
News
Cancer centre roof collapse closes beds
A leaking roof at a regional cancer centre forced the closure of 15 out of 60 beds last week and led to the suspension of 20 patient treatments.
-
News
10-month cancer delay casts doubt on ability to improve
Cancer patients have been waiting up to 10 months for treatment, according to a national 'baseline audit' casting doubt on services' ability to improve at the pace demanded by the government and public.
-
News
New test for colon cancer in sight
Scientists have identified a potential new screening technique, using skin cells, to identify people with an inherited predisposition to colorectal and other types of cancer .
-
News
£10m available for cancer waiting-time initiatives
The government has announced that £10m will be made available for nationwide initiatives to cut cancer outpatient waiting times to support its two-week waiting-time pledge. Public health minister Yvette Cooper said most hospitals would use the money to streamline booking systems, while others would invest in additional staff and equipment. ...
-
News
In Brief: Cancer Black Care information centre
Home Office minister Paul Boateng opened the Cancer Black Care information centre in Hackney, east London, on Friday. The centre, a joint initiative between Cancer Black Care and Macmillan Cancer Relief, aims to inform healthcare professionals about cultural issues in cancer care.
-
News
Two-week cancer target 'backfires'
The government's two-week target for cancer referrals has backfired, forcing many women with breast cancer to wait several months to see a specialist, according to new evidence.
-
News
Improving cancer services: CHI's first task
Top of the Commission for Health Improvement's agenda is cancer care. A joint inquiry with the Audit Commission is scheduled for next year, working closely with the government's newly appointed cancer 'czar' Professor Mike Richards.
-
News
Greater focus on cancer as czar signs up
Health secretary Alan Milburn announced he was 'making cancer treatment a personal priority'as he appointed a cancer 'czar' this week.
-
News
Waiver pays for cancer boost
A VAT waiver lay behind health secretary Frank Dobson's announcement of a further boost to cancer services at the Labour Party conference.
-
News
Cash for cancer dogged by Lottery row
A £150m Lottery cash boost for cancer care provoked a row this week as managers called for a more consistent investment programme and a leading cancer specialist accused them of allowing essential machinery to go to 'rack and ruin'.
-
News
Use of Paclitaxel in ovarian cancer is justified
The congratulations offered by Dr Harding to those health authorities yet to make Paclitaxel available to their patients with ovarian cancer are misplaced. The evidence was summarised in Effective Health Care and is set out more fully in the research evidence volume of the Guidance on Commissioning Cancer Services - ...
-
News
In Brief: Screening for ovarian cancer may increasese
Screening for ovarian cancer may increasese, according to a pilot feasibility study. The study randomised more than 20,000 postmenopausal women aged over 45 into a screening and a control group. Those screened were offered annual measurements of the cancer antigen, Ca125, and ovarian ultrasonography. The study found that screening identified ...
-
News
In Brief: US urologists devise way to predict risk of recurrence of prostate cancer
US urologists have devised a way of predicting the risk of a recurrence of prostate cancer after a radical prostatectomy. Using a study sample of 1,997 men who had had a radical prostatectomy for localised prostate cancer, the urologists studied the time it took for the concentration of prostate-specific antigen ...